Mammalian Target of Rapamycin Complex I (mTORC1) activity in Ras homologue enriched in brain (Rheb)-deficient mouse embryonic fibroblasts

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Groenewoud, Marlous J ^a   Goorden, Susan M I ^b   Kassies, Jorien ^a   Pellis van Berkel, Wendy ^a   Lamb, Richard F ^c   Elgersma, Ype ^b   Zwartkruis, Fried J T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GUANOSINE TRIPHOSPHATASE; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; RAS PROTEIN; RHEB PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MULTIPROTEIN COMPLEX; NEUROPEPTIDE; RAPAMYCIN; RHEB PROTEIN, MOUSE; RPTOR PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE PROGRESSION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ANALYSIS; IMMUNOBLOTTING; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DEFICIENCY; FEMALE; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PREGNANCY; RNA INTERFERENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; FEMALE; FIBROBLASTS; GENE EXPRESSION; MICE; MICE, KNOCKOUT; MONOMERIC GTP-BINDING PROTEINS; MULTIPROTEIN COMPLEXES; NEUROPEPTIDES; PREGNANCY; RNA INTERFERENCE; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84896702221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081649     Document Type: Article

References (62)

1. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35. doi:10.1038/nrm3025. PubMed: 21157483.
2. Avruch J, Hara K, Lin Y, Liu M, Long X et al. (2006) Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25: 6361-6372. doi:10.1038/sj.onc.1209882. PubMed: 17041622. (Pubitemid 44596154)
3. Ma XM, Blenis J (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307-318. doi:10.1038/nrm2672. PubMed: 19339977.
4. Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD et al. (2011) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328: 1172-1176.
5. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D et al. (2003) Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5: 566-571. doi:10.1038/ncb996. PubMed: 12766776. (Pubitemid 36781092)
6. Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P et al. (2003) Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 5: 559-565. doi:10.1038/ncb995. PubMed: 12766775. (Pubitemid 36781091)
7. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10: 151-162. doi:10.1016/S1097-2765(02)00568-3. PubMed: 12150915. (Pubitemid 34876569)
8. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657. doi:10.1038/ncb839. PubMed: 12172553. (Pubitemid 34993700)
9. Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 18: 1533-1538. doi:10.1101/gad.1199104. PubMed: 15231735. (Pubitemid 38868905)
10. Kwiatkowski DJ, Manning BD (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14 spec No. 2: R251-R258. PubMed: 16244323.
11. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M et al. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457-1466. doi:10.1016/S1097-2765(03)00220-X. PubMed: 12820960. (Pubitemid 36776533)
12. Schalm SS, Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12: 632-639. doi:10.1016/S0960-9822(02)00762-5. PubMed: 11967149. (Pubitemid 34315846)
13. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175. doi:10.1016/S0092-8674(02)00808-5. PubMed: 12150925. (Pubitemid 34876545)
14. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A et al. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226. doi:10.1016/j.molcel.2008.03.003. PubMed: 18439900. (Pubitemid 351626684)
15. Carrière A, Cargnello M, Julien LA, Gao H, Bonneil E et al. (2008) Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol 18: 1269-1277. doi:10.1016/j.cub.2008.07.078. PubMed: 18722121.
16. Carriere A, Romeo Y, Acosta-Jaquez HA, Moreau J, Bonneil E et al. (2011) ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem 286: 567-577. doi:10.1074/jbc.M110.159046. PubMed: 21071439.
17. Wang L, Lawrence JC Jr., Sturgill TW, Harris TE (2009) Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. J Biol Chem 284: 14693-14697. doi:10.1074/jbc.C109.002907. PubMed: 19346248.
18. Foster KG, Acosta-Jaquez HA, Romeo Y, Ekim B, Soliman GA et al. (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 285: 80-94. PubMed: 19864431.
19. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323. doi:10.1038/ncb1547. PubMed: 17277771. (Pubitemid 46344611)
20. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA et al. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25: 903-915. doi:10.1016/j.molcel.2007.03.003. PubMed: 17386266. (Pubitemid 46436534)
21. Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 282: 20329-20339. doi:10.1074/jbc.M702636200. PubMed: 17517883. (Pubitemid 47100038)
22. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C et al. (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273: 14484-14494. doi:10.1074/jbc.273.23.14484. PubMed: 9603962. (Pubitemid 28319170)
23. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY et al. (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A 102: 14238-14243. doi:10.1073/pnas.0506925102. PubMed: 16176982. (Pubitemid 41429682)
24. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10: 935-945. doi:10.1038/ncb1753. PubMed: 18604198.
25. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC et al. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320: 1496-1501. doi:10.1126/science.1157535. PubMed: 18497260.
26. van Dam TJ, Zwartkruis FJ, Bos JL, Snel B (2011) Evolution of the TOR Pathway. J Mol Evol, 73: 209-20. PubMed: 22057117.
27. Soulard A, Cohen A, Hall MN (2009) TOR signaling in invertebrates. Curr Opin Cell Biol 21: 825-836. doi:10.1016/j.ceb.2009.08.007. PubMed: 19767189.
28. Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y et al. (2007) S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab 5: 476-487. doi:10.1016/j.cmet.2007.05.006. PubMed: 17550782. (Pubitemid 46825498)
29. Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM (2010) mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468: 1100-1104. doi:10.1038/nature09584. PubMed: 21179166.
30. Polak P, Cybulski N, Feige JN, Auwerx J, Rüegg MA et al. (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 8: 399-410. doi:10.1016/j.cmet.2008.09. 003. PubMed: 19046571.
31. Gangloff YG, Mueller M, Dann SG, Svoboda P, Sticker M et al. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24: 9508-9516. doi:10.1128/MCB.24.21.9508-9516.2004. PubMed: 15485918. (Pubitemid 39391687)
32. Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K et al. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710-6718. doi:10.1128/MCB.24.15.6710-6718.2004. PubMed: 15254238. (Pubitemid 38944350)
33. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY et al. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-871. doi:10.1016/j.devcel.2006.10.007. PubMed: 17141160. (Pubitemid 44804279)
34. Goorden SM, Hoogeveen-Westerveld M, Cheng C, van Woerden GM, Mozaffari M et al. (2011) Rheb is essential for murine development. Mol Cell Biol 31: 1672-1678. doi:10.1128/MCB.00985-10. PubMed: 21321084.
35. Zou J, Zhou L, Du XX, Ji Y, Xu J et al. (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell 20: 97-108. doi:10.1016/j.devcel.2010.11.020. PubMed: 21238928.
36. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M et al. (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431: 200-205. doi:10.1038/nature02866. PubMed: 15306821. (Pubitemid 39243474)
37. Tee AR, Blenis J, Proud CG (2005) Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett 579: 4763-4768. doi:10.1016/j.febslet. 2005.07.054. PubMed: 16098514. (Pubitemid 41218660)
38. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT et al. (1999) Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13: 1422-1437. doi:10.1101/gad.13.11.1422. PubMed: 10364159. (Pubitemid 29270247)
39. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J et al. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023-8032. doi:10.1074/jbc.M900301200. PubMed: 19150980.
40. Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 105: 17414-17419. doi:10.1073/pnas.0809136105. PubMed: 18955708.
41. Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG (2005) Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 25: 2558-2572. doi:10.1128/MCB.25.7.2558-2572.2005. PubMed: 15767663. (Pubitemid 40381622)
42. Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci U S A 101: 13489-13494. doi:10.1073/pnas.0405659101. PubMed: 15342917. (Pubitemid 39238430)
43. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179-193. doi:10.1016/j.cell.2005.02.031. PubMed: 15851026. (Pubitemid 40546387)
44. Foster KG, Acosta-Jaquez HA, Romeo Y, Ekim B, Soliman GA et al. (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 285: 80-94. doi:10.1074/jbc.M109.029637. PubMed: 19864431.
45. Chen S, Mackintosh C (2009) Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes. Cell Signal 21: 1984-1993. doi:10.1016/j.cellsig.2009.09. 009. PubMed: 19765648.
46. Fonseca BD, Alain T, Finestone LK, Huang BP, Rolfe M et al. (2011) Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90(RSK) in the control of mTORC1 protein signaling by phorbol esters. J Biol Chem 286: 27111-27122. doi:10.1074/jbc.M111. 260794. PubMed: 21659537.
47. Abs E, Goorden SM, Schreiber J, Overwater IE, Hoogeveen-Westerveld M et al. (2013) TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice. Ann Neurol: ([MedlinePgn:]) PubMed: 23720219.
48. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168. doi:10.1016/j.molcel.2006.03.029. PubMed: 16603397.
49. Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005) Rheb binds and regulates the mTOR kinase. Curr Biol 15: 702-713. doi:10.1016/j.cub.2005.02.053. PubMed: 15854902. (Pubitemid 40599924)
50. Dunlop EA, Dodd KM, Seymour LA, Tee AR (2009) Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition. Cell Signal 21: 1073-1084. doi:10.1016/j.cellsig.2009.02. 024. PubMed: 19272448.
51. Wang L, Rhodes CJ, Lawrence JC Jr. (2006) Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1. J Biol Chem 281: 24293-24303. doi:10.1074/jbc. M603566200. PubMed: 16798736. (Pubitemid 44274202)
52. Rapley J, Oshiro N, Ortiz-Vega S, Avruch J (2011) The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. J Biol Chem 286: 38043-38053. doi:10.1074/jbc.M111.245449. PubMed: 21914810.
53. Sato T, Nakashima A, Guo L, Tamanoi F (2009) Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J Biol Chem 284: 12783-12791. doi:10.1074/jbc.M809207200. PubMed: 19299511.
54. Bai X, Ma D, Liu A, Shen X, Wang QJ et al. (2007) Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318: 977-980. doi:10.1126/science.1147379. PubMed: 17991864. (Pubitemid 350098994)
55. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S et al. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141: 290-303. doi:10.1016/j.cell.2010. 02.024. PubMed: 20381137.
56. Yan L, Mieulet V, Burgess D, Findlay GM, Sully K et al. (2010) PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Mol Cell 37: 633-642. doi:10.1016/j.molcel.2010.01.031. PubMed: 20227368.
57. Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P et al. (2011) Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem 286: 25477-25486. doi:10.1074/jbc.M111.249631. PubMed: 21622984.
58. Yoon MS, Du G, Backer JM, Frohman MA, Chen J (2011) Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol 195: 435-447. doi:10.1083/jcb.201107033. PubMed: 22024166.
59. Jaber N, Dou Z, Lin RZ, Zhang J, Zong WX (2012) Mammalian PIK3C3/VPS34: the key to autophagic processing in liver and heart. Autophagy 8: 707-708. doi:10.4161/auto.19627. PubMed: 22498475.
60. Choo AY, Kim SG, Vander Heiden MG, Mahoney SJ, Vu H et al. (2010) Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell 38: 487-499. doi:10.1016/j.molcel.2010. 05.007. PubMed: 20513425.
61. Hidalgo M, Rowinsky EK (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19: 6680-6686. doi:10.1038/sj.onc.1204091. PubMed: 11426655. (Pubitemid 32197708)
62. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265. doi:10.1038/nature07935. PubMed: 19329995.